Hangzhou Sciwind Biosciences Co., Ltd.
Clinical trials sponsored by Hangzhou Sciwind Biosciences Co., Ltd., explained in plain language.
-
New diabetes drug shows promise in phase 3 trial
Disease control CompletedThis study tested a new medication called XW003 in 211 adults with type 2 diabetes whose blood sugar was not well controlled by diet and exercise alone. Participants received either XW003 or a placebo to see if the drug could safely lower blood sugar levels. The main goal was to …
Phase: PHASE3 • Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:16 UTC
-
New obesity drug tested in teens – early safety results in
Disease control CompletedThis early-stage study tested an investigational drug called XW003 in 48 Chinese teenagers with obesity. The main goal was to check safety and how the drug moves through the body, while also measuring weight changes. Participants received multiple doses of the drug or a placebo, …
Phase: PHASE1 • Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC